Sign in
4

Changes in Ownership

Mineralys Therapeutics, Inc. Filed Acc 0001933414-24-000046

Chief Medical Officer acquired 10,369 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Rodman David Malcom Chief Medical Officer 2024-10-11 Option exercise +5,017 $0.54 $2,709 130,622 D
Rodman David Malcom Chief Medical Officer 2024-10-14 Option exercise +5,352 $1.08 $5,780 135,974 D
Derivatives
Rodman David Malcom Chief Medical Officer 2024-10-11 Option exercise · Stock Option −5,017 15,052 D
Rodman David Malcom Chief Medical Officer 2024-10-14 Option exercise · Stock Option −5,352 165,434 D
Loading xslF345X05/wk-form4_1729023724.xml…